Logo image
Sign in
Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer
Journal article   Peer reviewed

Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer

K. S. Tewari, R. N. Eskander and Bradley J. Monk
Clinical Cancer Research
07/13/2015
PMID: 26169965

Metrics

6 Record Views

Details